FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2126268610> ?p ?o ?g. }

• W2126268610 endingPage "1698" @default.
• W2126268610 startingPage "1688" @default.
• W2126268610 abstract "ABSTRACT The effects of ceftizoxime (CZX), piperacillin (PIP), and PIP-tazobactam (PT) concentrations on the antibacterial activity and selection of resistant mutants of Bacteroides fragilis and Enterobacter cloacae were investigated in vitro in a mixed-culture anaerobic time-kill study and in vivo in a mixed-infection abscess model. Mixed cultures were incubated for 24 h with 0.125 to 512 μg of CZX per ml or 0.125 to 2,048 μg of PIP or PT per ml. Mice were treated every 2 h for 24 h with CZX at 6 to 1,536 mg/kg/day or with PIP or PT at 24 to 6,144 mg/kg/day starting 30 min before inoculation with different B. fragilis - E. cloacae combinations. There was a good correlation between the in vitro and in vivo activities of the antibiotics and their MICs obtained with high inocula (10 8 CFU/ml). The respective 50% effective doses (milligrams per kilogram per day) with B. fragilis and E. cloacae 22491 were 771 and 521 for CZX, 416 and 643 for PIP, and 85 and 554 for PT, and with the B. fragilis - E. cloacae 032349 combination, they were 81 and 21 for CZX and 77 and 766 for PT. Resistant mutants of E. cloacae 22491 were preferentially selected in vitro with 2 to 64 μg of CZX per ml and in vivo with CZX at 12 to 384 mg/kg/day. There was no preferential selection of CZX-resistant B. fragilis or E. cloacae 032349. For CZX-resistant E. cloacae 22491, we found a 16- to 512-fold increase in the MIC of CZX and increased MICs of other expanded-spectrum cephalosporins, owing in part to the production of a stably derepressed cephalosporinase. In vitro and in vivo, PT did not select resistant mutants of E. cloacae and B. fragilis . Results demonstrate the adverse microbiological outcome of choosing an expanded-spectrum cephalosporin like CZX for empirical treatment of mixed infections involving a susceptible Enterobacter strain." @default.
• W2126268610 created "2016-06-24" @default.
• W2126268610 creator A5002028221 @default.
• W2126268610 creator A5042701741 @default.
• W2126268610 creator A5055038094 @default.
• W2126268610 creator A5064527266 @default.
• W2126268610 creator A5071608109 @default.
• W2126268610 creator A5080080592 @default.
• W2126268610 date "2004-05-01" @default.
• W2126268610 modified "2023-10-12" @default.
• W2126268610 title "Comparative Study of the Effects of Ceftizoxime, Piperacillin, and Piperacillin-Tazobactam Concentrations on Antibacterial Activity and Selection of Antibiotic-Resistant Mutants of <i>Enterobacter cloacae</i> and <i>Bacteroides fragilis</i> In Vitro and In Vivo in Mixed-Infection Abscesses" @default.
• W2126268610 cites W1744685958 @default.
• W2126268610 cites W1963659521 @default.
• W2126268610 cites W1967680704 @default.
• W2126268610 cites W1984031356 @default.
• W2126268610 cites W1991665650 @default.
• W2126268610 cites W2019235971 @default.
• W2126268610 cites W2023617320 @default.
• W2126268610 cites W2031261031 @default.
• W2126268610 cites W2034887731 @default.
• W2126268610 cites W2047400595 @default.
• W2126268610 cites W2053662694 @default.
• W2126268610 cites W2078229214 @default.
• W2126268610 cites W2087828860 @default.
• W2126268610 cites W2097999145 @default.
• W2126268610 cites W2098451641 @default.
• W2126268610 cites W2100747031 @default.
• W2126268610 cites W2103641272 @default.
• W2126268610 cites W2104004333 @default.
• W2126268610 cites W2111536213 @default.
• W2126268610 cites W2113396238 @default.
• W2126268610 cites W2116065309 @default.
• W2126268610 cites W2117014230 @default.
• W2126268610 cites W2120559051 @default.
• W2126268610 cites W2121789287 @default.
• W2126268610 cites W2122532040 @default.
• W2126268610 cites W2129905020 @default.
• W2126268610 cites W2131061532 @default.
• W2126268610 cites W2134875483 @default.
• W2126268610 cites W2144529399 @default.
• W2126268610 cites W2144700531 @default.
• W2126268610 cites W2159861657 @default.
• W2126268610 cites W2161870065 @default.
• W2126268610 cites W2163780760 @default.
• W2126268610 cites W2323959006 @default.
• W2126268610 cites W303529224 @default.
• W2126268610 doi "https://doi.org/10.1128/aac.48.5.1688-1698.2004" @default.
• W2126268610 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/400531" @default.
• W2126268610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15105122" @default.
• W2126268610 hasPublicationYear "2004" @default.
• W2126268610 type Work @default.
• W2126268610 sameAs 2126268610 @default.
• W2126268610 citedByCount "21" @default.
• W2126268610 countsByYear W21262686102012 @default.
• W2126268610 countsByYear W21262686102013 @default.
• W2126268610 countsByYear W21262686102015 @default.
• W2126268610 countsByYear W21262686102016 @default.
• W2126268610 countsByYear W21262686102018 @default.
• W2126268610 countsByYear W21262686102019 @default.
• W2126268610 countsByYear W21262686102020 @default.
• W2126268610 countsByYear W21262686102021 @default.
• W2126268610 countsByYear W21262686102022 @default.
• W2126268610 countsByYear W21262686102023 @default.
• W2126268610 crossrefType "journal-article" @default.
• W2126268610 hasAuthorship W2126268610A5002028221 @default.
• W2126268610 hasAuthorship W2126268610A5042701741 @default.
• W2126268610 hasAuthorship W2126268610A5055038094 @default.
• W2126268610 hasAuthorship W2126268610A5064527266 @default.
• W2126268610 hasAuthorship W2126268610A5071608109 @default.
• W2126268610 hasAuthorship W2126268610A5080080592 @default.
• W2126268610 hasBestOaLocation W21262686101 @default.
• W2126268610 hasConcept C104317684 @default.
• W2126268610 hasConcept C185592680 @default.
• W2126268610 hasConcept C2776869330 @default.
• W2126268610 hasConcept C2777402170 @default.
• W2126268610 hasConcept C2777637488 @default.
• W2126268610 hasConcept C2777858937 @default.
• W2126268610 hasConcept C2778193466 @default.
• W2126268610 hasConcept C2778266534 @default.
• W2126268610 hasConcept C2778910516 @default.
• W2126268610 hasConcept C2779631663 @default.
• W2126268610 hasConcept C2780246119 @default.
• W2126268610 hasConcept C501593827 @default.
• W2126268610 hasConcept C523546767 @default.
• W2126268610 hasConcept C54355233 @default.
• W2126268610 hasConcept C547475151 @default.
• W2126268610 hasConcept C55493867 @default.
• W2126268610 hasConcept C64778159 @default.
• W2126268610 hasConcept C86803240 @default.
• W2126268610 hasConcept C89423630 @default.
• W2126268610 hasConcept C94665300 @default.
• W2126268610 hasConceptScore W2126268610C104317684 @default.
• W2126268610 hasConceptScore W2126268610C185592680 @default.
• W2126268610 hasConceptScore W2126268610C2776869330 @default.
• W2126268610 hasConceptScore W2126268610C2777402170 @default.
• W2126268610 hasConceptScore W2126268610C2777637488 @default.
• W2126268610 hasConceptScore W2126268610C2777858937 @default.
• W2126268610 hasConceptScore W2126268610C2778193466 @default.

• next